View in EDS

Novel myo-inositol to butyrate fermentation pathway in the prevalent human gut species Dysosmobacter welbionis, a bacterium associated with improved metabolic and liver health.

Saved in:
Bibliographic Details
Title: Novel myo-inositol to butyrate fermentation pathway in the prevalent human gut species Dysosmobacter welbionis, a bacterium associated with improved metabolic and liver health.
Authors: Lee CH; Louvain Drug Research Institute (LDRI), Metabolism and Nutrition research group (MNUT), UCLouvain, Université catholique de Louvain, Brussels, Belgium.; Walloon Excellence in LifeSciences and BIOtechnology (WELBIO) department, WELResearch Institute, Wavre, Belgium., Bui TPN; Departments of Experimental Vascular Medicine, Amsterdam University Medical Centres (AMC), Amsterdam, Netherlands., Petitfils C; Louvain Drug Research Institute (LDRI), Metabolism and Nutrition research group (MNUT), UCLouvain, Université catholique de Louvain, Brussels, Belgium.; Walloon Excellence in LifeSciences and BIOtechnology (WELBIO) department, WELResearch Institute, Wavre, Belgium., Jian C; Human Microbiome Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland., Wong GC; Louvain Drug Research Institute (LDRI), Metabolism and Nutrition research group (MNUT), UCLouvain, Université catholique de Louvain, Brussels, Belgium.; Walloon Excellence in LifeSciences and BIOtechnology (WELBIO) department, WELResearch Institute, Wavre, Belgium., Puel A; Louvain Drug Research Institute (LDRI), Metabolism and Nutrition research group (MNUT), UCLouvain, Université catholique de Louvain, Brussels, Belgium.; Walloon Excellence in LifeSciences and BIOtechnology (WELBIO) department, WELResearch Institute, Wavre, Belgium., Le Roy T; Nutrition and obesities : systemic approaches, Nutriomics, Sorbonne Université, Inserm, Paris, France., Bellais S; BIOASTER, Lyon, France., Ben Abdallah B; BIOASTER, Lyon, France., Nehlich M; BIOASTER, Lyon, France., Leicht T; BIOASTER, Lyon, France., Jia M; Section of Biomolecular Medicine, Division of Systems Medicine, Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK., Hoyles L; Department of Biosciences, School of Science & Technology, Nottingham Trent University, Nottingham, UK., Federici M; IRCCS Neuromed, Pozzilli, Italy.; Department of Systems Medicine, Center for Atherosclerosis, University of Rome Tor Vergata, Rome, Italy., Fernández-Real JM; Department of Medical Sciences, School of Medicine, University of Girona, Girona, Spain.; CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Instituto de Salud Carlos III, Madrid, Spain.; Department of Diabetes, Endocrinology and Nutrition, Dr. Josep Trueta University Hospital, Girona, Spain., Burcelin R; UMR 1297 INSERM, Team INCOMM, Rangueil Hospital, Toulouse, France., Dumas ME; Section of Biomolecular Medicine, Division of Systems Medicine, Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK.; European Genomic Institute for Diabetes, U1283 INSERM, UMR8199 CNRS, Institut Pasteur de Lille, Lille University Hospital, University of Lille, Lille, France., Delzenne NM; Louvain Drug Research Institute (LDRI), Metabolism and Nutrition research group (MNUT), UCLouvain, Université catholique de Louvain, Brussels, Belgium., Clavel T; Functional Microbiome Research Group, Institute of Medical Microbiology, University Hospital of RWTH Aachen, Aachen, Germany., Boeren S; Biochemistry, Wageningen University, Wageningen, Netherlands., Troise AD; Proteomics, Metabolomics & Mass Spectrometry Laboratory, ISPAAM, National Research Council, Portici, Italy., Scaloni A; Proteomics, Metabolomics & Mass Spectrometry Laboratory, ISPAAM, National Research Council, Portici, Italy., Muccioli GG; Bioanalysis and Pharmacology of Bioactive Lipids Research Group (BPBL), Louvain Drug Research Institute (LDRI), UCLouvain, Université catholique de Louvain, Brussels, Belgium., De Vos WM; Departments of Experimental Vascular Medicine, Amsterdam University Medical Centres (AMC), Amsterdam, Netherlands.; Human Microbiome Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; Laboratory of Microbiology, Wageningen University, Wageningen, Netherlands., Van Hul M; Louvain Drug Research Institute (LDRI), Metabolism and Nutrition research group (MNUT), UCLouvain, Université catholique de Louvain, Brussels, Belgium patrice.cani@uclouvain.be Matthias.Vanhul@uclouvain.be.; Walloon Excellence in LifeSciences and BIOtechnology (WELBIO) department, WELResearch Institute, Wavre, Belgium., Cani PD; Louvain Drug Research Institute (LDRI), Metabolism and Nutrition research group (MNUT), UCLouvain, Université catholique de Louvain, Brussels, Belgium patrice.cani@uclouvain.be Matthias.Vanhul@uclouvain.be.; Walloon Excellence in LifeSciences and BIOtechnology (WELBIO) department, WELResearch Institute, Wavre, Belgium.; Section of Biomolecular Medicine, Division of Systems Medicine, Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK.; Institute of Experimental and Clinical Research (IREC), UCLouvain, Université catholique de Louvain, Brussels, Belgium.
Source: Gut [Gut] 2026 Jun 09; Vol. 75 (7), pp. 1338-1352. Date of Electronic Publication: 2026 Jun 09.
Publication Type: Journal Article
Journal Info: Publisher: British Medical Assn Country of Publication: England NLM ID: 2985108R Publication Model: Electronic Cited Medium: Internet ISSN: 1468-3288 (Electronic) Linking ISSN: 00175749 NLM ISO Abbreviation: Gut Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41500802
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Novel myo-inositol to butyrate fermentation pathway in the prevalent human gut species Dysosmobacter welbionis, a bacterium associated with improved metabolic and liver health.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Lee+CH%22">Lee CH</searchLink>; Louvain Drug Research Institute (LDRI), Metabolism and Nutrition research group (MNUT), UCLouvain, Université catholique de Louvain, Brussels, Belgium.; Walloon Excellence in LifeSciences and BIOtechnology (WELBIO) department, WELResearch Institute, Wavre, Belgium.<br /><searchLink fieldCode="AU" term="%22Bui+TPN%22">Bui TPN</searchLink>; Departments of Experimental Vascular Medicine, Amsterdam University Medical Centres (AMC), Amsterdam, Netherlands.<br /><searchLink fieldCode="AU" term="%22Petitfils+C%22">Petitfils C</searchLink>; Louvain Drug Research Institute (LDRI), Metabolism and Nutrition research group (MNUT), UCLouvain, Université catholique de Louvain, Brussels, Belgium.; Walloon Excellence in LifeSciences and BIOtechnology (WELBIO) department, WELResearch Institute, Wavre, Belgium.<br /><searchLink fieldCode="AU" term="%22Jian+C%22">Jian C</searchLink>; Human Microbiome Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.<br /><searchLink fieldCode="AU" term="%22Wong+GC%22">Wong GC</searchLink>; Louvain Drug Research Institute (LDRI), Metabolism and Nutrition research group (MNUT), UCLouvain, Université catholique de Louvain, Brussels, Belgium.; Walloon Excellence in LifeSciences and BIOtechnology (WELBIO) department, WELResearch Institute, Wavre, Belgium.<br /><searchLink fieldCode="AU" term="%22Puel+A%22">Puel A</searchLink>; Louvain Drug Research Institute (LDRI), Metabolism and Nutrition research group (MNUT), UCLouvain, Université catholique de Louvain, Brussels, Belgium.; Walloon Excellence in LifeSciences and BIOtechnology (WELBIO) department, WELResearch Institute, Wavre, Belgium.<br /><searchLink fieldCode="AU" term="%22Le+Roy+T%22">Le Roy T</searchLink>; Nutrition and obesities : systemic approaches, Nutriomics, Sorbonne Université, Inserm, Paris, France.<br /><searchLink fieldCode="AU" term="%22Bellais+S%22">Bellais S</searchLink>; BIOASTER, Lyon, France.<br /><searchLink fieldCode="AU" term="%22Ben+Abdallah+B%22">Ben Abdallah B</searchLink>; BIOASTER, Lyon, France.<br /><searchLink fieldCode="AU" term="%22Nehlich+M%22">Nehlich M</searchLink>; BIOASTER, Lyon, France.<br /><searchLink fieldCode="AU" term="%22Leicht+T%22">Leicht T</searchLink>; BIOASTER, Lyon, France.<br /><searchLink fieldCode="AU" term="%22Jia+M%22">Jia M</searchLink>; Section of Biomolecular Medicine, Division of Systems Medicine, Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Hoyles+L%22">Hoyles L</searchLink>; Department of Biosciences, School of Science & Technology, Nottingham Trent University, Nottingham, UK.<br /><searchLink fieldCode="AU" term="%22Federici+M%22">Federici M</searchLink>; IRCCS Neuromed, Pozzilli, Italy.; Department of Systems Medicine, Center for Atherosclerosis, University of Rome Tor Vergata, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Fernández-Real+JM%22">Fernández-Real JM</searchLink>; Department of Medical Sciences, School of Medicine, University of Girona, Girona, Spain.; CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Instituto de Salud Carlos III, Madrid, Spain.; Department of Diabetes, Endocrinology and Nutrition, Dr. Josep Trueta University Hospital, Girona, Spain.<br /><searchLink fieldCode="AU" term="%22Burcelin+R%22">Burcelin R</searchLink>; UMR 1297 INSERM, Team INCOMM, Rangueil Hospital, Toulouse, France.<br /><searchLink fieldCode="AU" term="%22Dumas+ME%22">Dumas ME</searchLink>; Section of Biomolecular Medicine, Division of Systems Medicine, Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK.; European Genomic Institute for Diabetes, U1283 INSERM, UMR8199 CNRS, Institut Pasteur de Lille, Lille University Hospital, University of Lille, Lille, France.<br /><searchLink fieldCode="AU" term="%22Delzenne+NM%22">Delzenne NM</searchLink>; Louvain Drug Research Institute (LDRI), Metabolism and Nutrition research group (MNUT), UCLouvain, Université catholique de Louvain, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Clavel+T%22">Clavel T</searchLink>; Functional Microbiome Research Group, Institute of Medical Microbiology, University Hospital of RWTH Aachen, Aachen, Germany.<br /><searchLink fieldCode="AU" term="%22Boeren+S%22">Boeren S</searchLink>; Biochemistry, Wageningen University, Wageningen, Netherlands.<br /><searchLink fieldCode="AU" term="%22Troise+AD%22">Troise AD</searchLink>; Proteomics, Metabolomics & Mass Spectrometry Laboratory, ISPAAM, National Research Council, Portici, Italy.<br /><searchLink fieldCode="AU" term="%22Scaloni+A%22">Scaloni A</searchLink>; Proteomics, Metabolomics & Mass Spectrometry Laboratory, ISPAAM, National Research Council, Portici, Italy.<br /><searchLink fieldCode="AU" term="%22Muccioli+GG%22">Muccioli GG</searchLink>; Bioanalysis and Pharmacology of Bioactive Lipids Research Group (BPBL), Louvain Drug Research Institute (LDRI), UCLouvain, Université catholique de Louvain, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22De+Vos+WM%22">De Vos WM</searchLink>; Departments of Experimental Vascular Medicine, Amsterdam University Medical Centres (AMC), Amsterdam, Netherlands.; Human Microbiome Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; Laboratory of Microbiology, Wageningen University, Wageningen, Netherlands.<br /><searchLink fieldCode="AU" term="%22Van+Hul+M%22">Van Hul M</searchLink>; Louvain Drug Research Institute (LDRI), Metabolism and Nutrition research group (MNUT), UCLouvain, Université catholique de Louvain, Brussels, Belgium patrice.cani@uclouvain.be Matthias.Vanhul@uclouvain.be.; Walloon Excellence in LifeSciences and BIOtechnology (WELBIO) department, WELResearch Institute, Wavre, Belgium.<br /><searchLink fieldCode="AU" term="%22Cani+PD%22">Cani PD</searchLink>; Louvain Drug Research Institute (LDRI), Metabolism and Nutrition research group (MNUT), UCLouvain, Université catholique de Louvain, Brussels, Belgium patrice.cani@uclouvain.be Matthias.Vanhul@uclouvain.be.; Walloon Excellence in LifeSciences and BIOtechnology (WELBIO) department, WELResearch Institute, Wavre, Belgium.; Section of Biomolecular Medicine, Division of Systems Medicine, Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK.; Institute of Experimental and Clinical Research (IREC), UCLouvain, Université catholique de Louvain, Brussels, Belgium.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%222985108R%22">Gut</searchLink> [Gut] 2026 Jun 09; Vol. 75 (7), pp. 1338-1352. <i>Date of Electronic Publication: </i>2026 Jun 09.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22British+Medical+Assn%22">British Medical Assn </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>2985108R <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1468-3288 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200175749%22">00175749 </searchLink><i>NLM ISO Abbreviation: </i>Gut <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41500802
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1136/gutjnl-2025-336617
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1338
    Titles:
      – TitleFull: Novel myo-inositol to butyrate fermentation pathway in the prevalent human gut species Dysosmobacter welbionis, a bacterium associated with improved metabolic and liver health.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Lee CH
      – PersonEntity:
          Name:
            NameFull: Bui TPN
      – PersonEntity:
          Name:
            NameFull: Petitfils C
      – PersonEntity:
          Name:
            NameFull: Jian C
      – PersonEntity:
          Name:
            NameFull: Wong GC
      – PersonEntity:
          Name:
            NameFull: Puel A
      – PersonEntity:
          Name:
            NameFull: Le Roy T
      – PersonEntity:
          Name:
            NameFull: Bellais S
      – PersonEntity:
          Name:
            NameFull: Ben Abdallah B
      – PersonEntity:
          Name:
            NameFull: Nehlich M
      – PersonEntity:
          Name:
            NameFull: Leicht T
      – PersonEntity:
          Name:
            NameFull: Jia M
      – PersonEntity:
          Name:
            NameFull: Hoyles L
      – PersonEntity:
          Name:
            NameFull: Federici M
      – PersonEntity:
          Name:
            NameFull: Fernández-Real JM
      – PersonEntity:
          Name:
            NameFull: Burcelin R
      – PersonEntity:
          Name:
            NameFull: Dumas ME
      – PersonEntity:
          Name:
            NameFull: Delzenne NM
      – PersonEntity:
          Name:
            NameFull: Clavel T
      – PersonEntity:
          Name:
            NameFull: Boeren S
      – PersonEntity:
          Name:
            NameFull: Troise AD
      – PersonEntity:
          Name:
            NameFull: Scaloni A
      – PersonEntity:
          Name:
            NameFull: Muccioli GG
      – PersonEntity:
          Name:
            NameFull: De Vos WM
      – PersonEntity:
          Name:
            NameFull: Van Hul M
      – PersonEntity:
          Name:
            NameFull: Cani PD
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 09
              M: 06
              Text: 2026 Jun 09
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1468-3288
          Numbering:
            – Type: volume
              Value: 75
            – Type: issue
              Value: 7
          Titles:
            – TitleFull: Gut
              Type: main
ResultId 1